A multi-center, open-label study to evaluate the safety and efficacy of a sequential treatment regimen of clobetasol propionate 0.05% spray followed by calcitriol 3 mg/g ointment in the management of plaque psoriasis

Journal of Drugs in Dermatology

Volumn 10, Issue 2, 2011, Pages 158-164

  Brodell, Robert T ^a   Bruce, Suzanne ^b   Hudson, Charles P ^c   Weiss, Jonathan S ^d   Colón, Luz E ^e   Johnson, Lori A ^e   Gottschalk, Ronald W ^e  

^a NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^b Suzanne Bruce and Associates   (United States)

^c Hudson Dermatology   (United States)

^d Gwinnett Clinical Research Center Inc   (United States)

^e Galderma Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CLOBETASOL PROPIONATE; ANTIINFLAMMATORY AGENT; CLOBETASOL; VITAMIN;

ADULT; ARTICLE; BODY SURFACE; BURNING SENSATION; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLICULITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; POPULATION; PRURITUS; PSORIASIS VULGARIS; SKIN ATROPHY; TELANGIECTASIA; TOPICAL TREATMENT; TREATMENT DURATION; DISEASE COURSE; DRUG ADMINISTRATION; DRUG COMBINATION; INTRADERMAL DRUG ADMINISTRATION; PSORIASIS; TIME; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ANTI-INFLAMMATORY AGENTS; CALCITRIOL; CLOBETASOL; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; PSORIASIS; TIME FACTORS; TREATMENT OUTCOME; VITAMINS;

EID: 80052073112     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Beutner K, Chakrabarty A, Lemke S, Yu K. An intra-individual randomized safety and efficacy comparison of clobetasol propionate 0.05% spray and its vehicle in the treatment of plaque psoriasis. J Drugs Dermatol. 2006;5(4):357-360.
2. Gelfand JM, Feldman SR, Stern RS, et al. Determinants of quality of life in patients with psoriasis: A study from the US population. J Am Acad Dermatol. 2004;51(5):704-708. (Pubitemid 39516879)
3. Krueger G, Koo J, Lebwohl M, et al. The impact of psoriasis on quality of life: Results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol. 2001;137(3):280-284. (Pubitemid 32240779)
4. Weiss SC, Bergstrom KG, Weiss SA, Kimball AB. Quality of life considerations in psoriasis treatment. Dermatol Nurs. 2003;15(2):120,123-127.
5. Van de Kerhof P. Psoriasis. Dermatology, ed. Mosby. 2003, St. Louis, MO.
6. Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med. 2009;361(5):496-509.
7. Menter A, Korman NJ, Elmets CA, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol. 2009;60(4):643-659.
8. Schoepe S, Schacke H, May E, Asadullah K. Glucocorticoid therapyinduced skin atrophy. Exp Dermatol. 2006;15(6):406-420.
9. Smith EL, Walworth NC, Holick MF. Walworth NC, Holick MF. Effect of 1 alpha,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions. J Invest Dermatol. 1986;86(6):709-714. (Pubitemid 16098227)
10. Ortonne JP, Humbert P, Nicolas JF, et al. Intra-individual comparison of the cutaneous safety and efficacy of calcitriol 3 microg g(-1) ointment and calcipotriol 50 microg g(-1) ointment on chronic plaque psoriasis localized in facial, hairline, retroauricular or flexural areas. Br J Dermatol. 2003;148(2):326-333. (Pubitemid 36278976)
11. Camarasa JM, Ortonne JP, Dubertret L. Calcitriol shows greater persistence of treatment effect than betamethasone dipropionate in topical psoriasis therapy. J Dermatolog Treat. 2003;14(1):8-13. (Pubitemid 36417421)
12. Lebwohl M, Ortonne JP, Andres P, Briantais P. Calcitriol ointment 3 microg/g is safe and effective over 52 weeks for the treatment of mild to moderate plaque psoriasis. Cutis. 2009;83(4):205-212.
13. Jarratt MT, Clark DS, Savin RC, et al. Evaluation of the efficacy and safety of clobetasol propionate spray in the treatment of plaquetype psoriasis. Cutis. 2006;78(5):348-354. (Pubitemid 44952097)
14. Lebwohl M, Menter A, Weiss J, et al. Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: Results from 2 placebo-controlled, multicenter, randomized doubleblind, clinical studies. J Drugs Dermatol. 2007;6(4):428-435.